Scored 5/10 on whether it helps or hurts everyday people.
The Managers & Drug Bill
Nebraska looks at pharmacy benefit managers and drug prices
Interim study to examine the role of a pharmacy benefit manager within the Nebraska health insurance industry and the impact on prescription drug prices
Mixed: some good, some bad ·
The bill would start a study of how pharmacy benefit managers affect drug prices in Nebraska, so lawmakers can decide if changes are needed.
Our take
What we think, in plain words.
If passed, the state will spend time and money to learn whether PBMs raise or lower prescription costs, which could shape future rules that affect what you pay for medicines.
Take action
Add your name. At 100 signatures we compile this petition and deliver it to the office — and every signer gets a message to send their own representatives.
0 of 100 in‑district signatures
Step 1 · Pick your position
Step 2 · Add your name
Sign in to oppose this billPicking a side above doesn't sign anything yet — a free account records your name on the petition and keeps it one signature per person. We'll bring you straight back here with your choice saved.
The facts
What the bill actually says, no spin.
- Bill proposes an interim study of pharmacy benefit managers in Nebraska health insurance.
- Study will examine the impact on prescription drug prices.
- Sponsored by Sen. Michael Jacobson.
- Referred to the Executive Board and the Banking, Commerce and Insurance Committee.
In the news
Scanning the news for this bill…
Headlines gathered from across the news, starting points to explore, not endorsements. Always read the official text before acting.
Sources
Read it yourself: the official bill and records.
This bill is in the Nebraska Bill Book 2026
The best and worst Nebraska bills of 2026, one page each — our take on the left, the bill on the right, and room for your notes. No email needed.
Get the free PDF →